Cipla's US sales are expected to be adversely impacted by price erosion and supply disruptions for tumor drug Lanreotide, ...

Cipla Ltd is one of the leading pharmaceutical companies in India ... Its 47 manufacturing sites around the world produce more than 50 dosage forms and over 1500 products across wide range of th ...

the consumer healthcare subsidiary of Cipla Ltd purchased the nutritional supplement brand Endura Mass from Medinnbelle Herbalcare. Products and services Cipla is among India’s biggest ...

Indian pharma companies like Dr Reddys, Zydus, Cipla, and Sun can sustain low double-digit EPS growth over the medium term.

Cipla Limited is an India-based global pharmaceutical company. The Company is engaged in manufacturing, developing and marketing a wide range of branded and generic formulations and Active ...

Cipla has launched a mobile application, CipAir, to aid in asthma screening in India, aiming to address the country's high asthma burden and underdiagnosis. India's pharmaceutical industry is poised ...

incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 1,13,986.65 Crore) operating in Pharmaceuticals sector. Cipla Ltd. key Products/Revenue Segments include ...

Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the ...

Cipla reported a net profit of ₹1,303 crore, marking a 15% increase compared to the same period last year.

Stocks like L&T Finance, Sunteck Realty, Jammu and Kashmir Bank, Prakash Industries, Bank of Baroda, Torrent Power, Landmark ...

The inspection focused on the subsidiary's practices and procedures related to Laurus Labs’ marketed products worldwide.